Airo (Other Pharmaceuticals and Biotechnology) is Other Pharmaceuticals and Biotechnology in United States that focus on CBD oils business. Founded in 2015. They cover business area such as developer, an alternative, oil vaporizer, cartridge, scented oil, hand, an extensive selection, strain, artisanal blend, taste, experience, consumer, cbd, its patented, closed system.
Other Pharmaceuticals and Biotechnology
2015
( 9 years old in 2024 )
CBD Oils
-
201 Edward Curry Avenue
Staten Island, NY 10314
United States
Private
developeran alternativeoil vaporizercartridgescented oilhandan extensive selectionstrainartisanal blendtasteexperienceconsumercbdits patented, closed system
* We use standard office opening hours in near Airo (Other Pharmaceuticals and Biotechnology)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Airo (Other Pharmaceuticals And Biotechnology) is Other Pharmaceuticals and Biotechnology business from United States that founded in 2015 (9 years old in 2024), Airo (Other Pharmaceuticals and Biotechnology) business is focusing on CBD Oils.
Airo (Other Pharmaceuticals and Biotechnology) headquarter office and corporate office address is located in 201 Edward Curry Avenue Staten Island, NY 10314 United States.
Airo (Other Pharmaceuticals and Biotechnology) was founded in United States.
In 2024, Airo (Other Pharmaceuticals and Biotechnology) is currently focus on CBD oils sector.
Above is snippet of Google Trends for "CBD oils" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Airo (Other Pharmaceuticals and Biotechnology), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
